S&P 500
(0.05%) 5 476.20 points
Dow Jones
(0.08%) 38 811 points
Nasdaq
(-0.03%) 17 852 points
Oil
(0.27%) $80.55
Gas
(0.65%) $2.81
Gold
(0.14%) $2 332.20
Silver
(-0.26%) $29.32
Platinum
(-0.05%) $970.40
USD/EUR
(0.01%) $0.932
USD/NOK
(-0.17%) $10.64
USD/GBP
(0.05%) $0.788
USD/RUB
(-1.86%) $86.80

Realaus laiko atnaujinimai ADMA Biologics Inc [ADMA]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Biotechnology
Atnaujinta18 birž. 2024 @ 16:31

0.24% $ 10.47

Live Chart Being Loaded With Signals

Commentary (18 birž. 2024 @ 16:31):
Our systems believe the stock currently is undervalued by 0.22% compare to its pairs and should correct upwards.
Profile picture for ADMA Biologics Inc

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally...

Stats
Šios dienos apimtis 37 419
Vidutinė apimtis 2.74M
Rinkos kapitalizacija 2.43B
EPS $0.0778 ( Q1 | 2024-05-09 )
Kita pelno data ( $0 ) 2024-08-07
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -523.25
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0120 (0.11%)
AADI 0.00%
ABCL 0.98%
ABCM 0.04%
ABEO 0.22%
ABIO 2.17%
ABOS -0.40%
ABSI -0.15%
ABUS 0.33%
ABVX -0.22%
ACAD 0.54%
ACER -17.95%
ACET 0.38%
ACGN 1.29%
ACHL -2.44%
ACHV 1.63%
ACIU 0.00%
ACLX 0.28%
ACRV 0.73%
ACST 0.62%
ACXP 1.68%
ADAG -5.64%
ADAP -0.62%
ADGI 0.87%
ADIL 1.57%
ADMA 0.24%
ADPT -0.96%
ADTX -1.27%
ADVM -0.55%
ADXN -6.11%
AEON 11.51%
AEZS -5.44%
AFMD -0.59%
AGEN -1.89%
AGIO 0.56%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW 53.45%
AKBA -0.95%
AKRO 0.26%
AKTX -2.70%
AKUS 0.00%
ALBO 0.00%
ALDX 3.34%
ALEC 0.44%
ALGS -0.25%
ALKS 0.34%
ALLK -0.85%
ALLO -0.87%
ALLR -2.32%
ALNA 3.16%
ALNY -0.01%
ALPN 0.00%
ALPX 0.00%
ALRN -0.31%
ALT -0.34%
ALVR 0.60%
ALXN 0.00%
ALXO -1.49%
ALZN 0.00%
AMRN -0.52%
AMTI -3.13%
ANAB -0.94%
ANEB -5.58%
ANGN 0.00%
ANIX -1.15%
ANL 0.61%
ANNX -0.65%
ANPC -3.15%
APGE 0.36%
APGN 8.48%
APGNW 30.65%
APLM 10.18%
APLS 0.78%
APLT 0.21%
APM 1.33%
APOP 0.38%
APRE 2.44%
APTO 0.68%
APTX 3.17%
APVO -0.02%
ARAV -13.39%
ARCT -0.44%
ARDS 20.48%
ARDX 0.00%
ARGX 0.19%
ARNA 0.00%
ARPO -0.90%
ARQT -1.51%
ARTL -4.55%
ARTLW 9.80%
ARVN -0.60%
ARWR -0.24%
ASLN 2.75%
ASMB -0.86%
ASND 0.41%
ATAI 0.37%
ATHA -0.38%
ATHE -1.61%
ATHX -33.50%
ATNF -4.37%
ATOS 0.89%
ATRA -2.10%
ATXI -1.66%
ATXS 0.45%
AUPH -0.36%
AURA 0.68%
AUTL -0.23%
AVBP -0.27%
AVEO 0.00%
AVIR -0.28%
AVRO -2.05%
AVTE -4.81%
AVTX 4.15%
AVXL 0.00%
AXLA 0.00%
AXSM 0.07%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.64%
BCAB 1.92%
BCDA -0.30%
BCDAW -33.33%
BCEL -1.32%
BCLI 1.23%
BCRX -0.24%
BCTX -0.68%
BCTXW 0.00%
BCYC 1.49%
BDRX 1.05%
BDTX -0.55%
BEAM -0.12%
BFRA -2.91%
BGNE -1.47%
BIOR 0.03%
BIVI 1.73%
BLCM -6.68%
BLI -5.88%
BLPH -0.79%
BLRX 2.36%
BLTE -0.72%
BLU 0.03%
BLUE -0.61%
BMEA -0.20%
BMRN 0.19%
BNOX 10.76%
BNTC 2.46%
BNTX 0.14%
BOLD 0.49%
BOLT -0.50%
BPMC 0.27%
BPTH 1.26%
BPTS -13.47%
BRNS 2.96%
BRTX -9.91%
BTAI 0.75%
BTTX -7.50%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 0.00%
CABA -1.41%
CADL -1.11%
CALA 60.00%
CALC -1.62%
CALT -0.64%
CAPR -0.60%
CARA 2.85%
CARM 0.97%
CASI -2.41%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 2.61%
CCCC -1.09%
CCXI 0.00%
CDAK 0.00%
CDIO -3.01%
CDIOW 0.00%
CDMO -0.40%
CDMOP 0.04%
CDT -6.11%
CDTTW 294.32%
CDTX -0.08%
CDXC -1.18%
CDXS -1.51%
CELC 0.99%
CELU 7.05%
CELUW -9.52%
CERC -1.68%
CERE 0.07%
CERO -4.31%
CEROW -44.78%
CFRX -27.95%
CGEM -1.87%
CGEN -1.02%
CGON 0.00%
CGTX 1.37%
CHMA -6.00%
CHRS -0.01%
CINC 0.00%
CING 4.48%
CINGW -48.24%
CKPT -0.49%
CLBS -16.75%
CLDX 2.89%
CLGN 0.30%
CLLS -6.54%
CLNN 0.37%
CLNNW -41.25%
CLRB 0.74%
CLSD 0.86%
CLSN -0.68%
CLVS 0.00%
CMMB 10.18%
CMND 2.73%
CMPI 0.00%
CMPX 0.00%
CMRA 0.40%
CMRAW 33.33%
CMRX 1.11%
CNCE 0.00%
CNSP -1.73%
CNST 0.00%
CNTA 0.31%
CNTB 3.13%
CNTX -1.03%
COCP 0.42%
COEPW -0.66%
COGT -0.11%
CORT -0.28%
COYA 2.22%
CPRX 0.00%
CRBP -2.67%
CRBU -0.28%
CRDF -0.75%
CRGX 0.00%
CRIS 0.73%
CRNX -0.16%
CRSP 0.38%
CRTX 2.63%
CRVO 1.97%
CRVS 0.00%
CSBR 1.19%
CTCX -8.04%
CTIC 0.06%
CTMX 3.65%
CTNM -2.94%
CTXR 1.43%
CUE -0.75%
CVAC 0.86%
CVKD 1.37%
CWBR -2.55%
CYAD -12.96%
CYCC -2.45%
CYCCP -1.79%
CYCN 6.00%
CYT -2.27%
CYTK -0.13%
CYTO -3.23%
DARE 1.19%
DAWN 0.42%
DBTX -0.81%
DBVT 1.01%
DFFN 10.28%
DICE 0.06%
DMAC -0.42%
DNLI 1.12%
DNTH 0.04%
DOMH 1.99%
DRMA 0.00%
DRMAW 0.00%
DRNA 0.00%
DRTS -1.32%
DRTSW 1.01%
DRUG 0.00%
DSGN 0.26%
DTIL -1.19%
DYAI -5.29%
EARS -1.77%
EDIT 3.75%
EDSA 1.04%
EFTR -3.13%
EFTRW -0.26%
EIGR 0.00%
ELAB -2.87%
ELDN 0.71%
ELEV -0.84%
ELOX -12.50%
ELTX -2.33%
ELVN -0.65%
ELYM 0.52%
ENGN -3.89%
ENGNW -5.29%
ENLV 0.73%
ENOB 1.79%
ENSC 0.88%
ENTA -0.75%
ENTO 0.48%
ENTX 1.45%
ENVB 3.24%
EPIX 0.00%
EPRX -0.19%
EPZM 0.00%
EQ 1.40%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.49%
ERNA 4.79%
ERYP 1.30%
ESLA 1.14%
ESLAW -9.25%
ETNB -0.23%
ETON 1.19%
ETTX 0.00%
EVAX 4.45%
EVGN -2.55%
EVLO 50.00%
EWTX -0.58%
EXAI -0.20%
EXEL -0.30%
EYEG -0.43%
EYEN -0.33%
EYPT -1.33%
FATE 0.42%
FBIO 0.21%
FBIOP 1.09%
FBLG -1.17%
FBRX -7.46%
FDMT -0.67%
FENC 0.74%
FGEN 0.47%
FHTX 9.52%
FIXX 0.77%
FMTX 0.00%
FNCH -6.25%
FOLD -0.30%
FREQ 4.76%
FRLN 0.15%
FRTX -0.54%
FSTX 0.00%
FTRE 0.58%
FULC 0.00%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT 3.20%
GANX -0.76%
GBIO 1.37%
GBT 0.01%
GDTC -7.21%
GERN -0.96%
GHRS 3.42%
GLMD -3.30%
GLPG 0.93%
GLSI -1.83%
GLTO 0.00%
GLUE 0.00%
GLYC 2.57%
GMAB 0.95%
GMDA 0.00%
GMTX 0.00%
GNCA -85.71%
GNFT 0.97%
GNLX 0.00%
GNPX 1.84%
GNTA 0.00%
GOSS 13.19%
GOVX 17.86%
GOVXW -24.72%
GPCR 0.93%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -1.42%
GRTX -4.26%
GTHX 0.38%
GUTS 0.28%
GXGXW 41.67%
GYRE 0.17%
HALO -0.01%
HARP 0.09%
HCWB -9.73%
HEPA -6.36%
HGEN -84.62%
HILS 5.66%
HLVX 0.00%
HOOK 0.56%
HOTH -3.73%
HOWL -1.27%
HRMY 0.00%
HRTX 1.66%
HSTO 62.16%
HUMA 0.65%
HUMAW -5.97%
IBRX 0.86%
ICCC 2.84%
ICPT 0.21%
ICU -0.26%
ICUCW -10.39%
ICVX -0.91%
IDRA -23.04%
IDYA -0.13%
IFRX -3.21%
IGMS 0.14%
IKNA 1.15%
IKT 8.90%
IMAB -1.10%
IMCR -0.81%
IMGN 0.02%
IMGO 0.00%
IMMP -1.49%
IMMX -0.49%
IMNM -0.99%
IMNN -0.90%
IMPL -27.27%
IMRA 15.96%
IMRN -2.78%
IMRX 0.32%
IMTX -0.85%
IMTXW -2.70%
IMUX 1.75%
IMV 0.00%
IMVT 0.11%
INAB -0.02%
INBX -0.35%
INCY 0.18%
INDP -3.03%
INFI -52.38%
INKT -0.39%
INM 1.46%
INMB -0.60%
INO 0.00%
INSM -0.23%
INTS 0.84%
INVA 1.55%
INZY 0.44%
IOBT -0.81%
IONS -0.37%
IOVA -0.25%
IPA 0.00%
IPHA -10.64%
IPSC 0.95%
IRON -0.69%
ISEE 0.38%
ITOS -0.84%
ITRM -2.61%
IVA 2.64%
IVVD 0.00%
JAGX -0.26%
JANX 0.17%
JAZZ 0.06%
JNCE 0.00%
JSPR -0.08%
JSPRW 2.33%
JUNS 0.00%
JUNSW 0%
KA -5.56%
KALV -0.42%
KDNY 0.22%
KMPH -0.34%
KNSA -0.05%
KNTE -0.38%
KOD 0.00%
KPRX 8.51%
KPTI -0.28%
KRBP 4.17%
KRON 0.00%
KROS -1.56%
KRRO -0.63%
KRTX 0.03%
KRYS -0.18%
KTRA 9.27%
KTTA -2.85%
KTTAW 8.62%
KURA 1.02%
KYMR -0.38%
KYTX -0.25%
KZIA 8.44%
KZR 0.65%
LABP 0.57%
LBPH -0.98%
LBPS 0.00%
LBPSW 14.81%
LEGN 0.19%
LENZ -1.30%
LEXX 2.73%
LEXXW -9.42%
LGND -0.46%
LGNDV 0.00%
LGVN -12.50%
LIAN 0.00%
LIFE 2.70%
LIPO -1.23%
LIXT 0.40%
LIXTW 27.74%
LJPC -0.32%
LMNL 0.12%
LOGC -0.72%
LPCN 2.99%
LPTX -0.25%
LQDA -0.23%
LRMR 1.13%
LSTA -4.97%
LTRN -2.24%
LUMO 0.00%
LVTX -1.42%
LXEO -1.05%
LXRX 1.16%
LYEL -0.45%
LYRA -1.26%
MACK 0.00%
MBIO 37.60%
MBRX -4.83%
MCRB -0.88%
MDGL 0.06%
MDNA -13.16%
MDWD 1.00%
MDXG 0.15%
MEIP 1.41%
MESO 2.07%
MGNX -2.46%
MGTA -7.74%
MGTX -1.14%
MGX 2.85%
MIRM 1.20%
MIRO 0.59%
MIST 2.96%
MITO 0.00%
MLEC -4.55%
MLECW 9.25%
MLND -5.36%
MLTX 0.09%
MLYS -0.66%
MNKD 0.00%
MNMD 1.14%
MNOV 0.00%
MNPR 3.39%
MOLN 2.88%
MOR -0.55%
MORF 1.34%
MREO 0.00%
MRKR -4.76%
MRNA -1.25%
MRNS 2.07%
MRSN 0.00%
MRTX -0.17%
MRUS -1.24%
MRVI 0.28%
MTCR -1.29%
MTEM 1.54%
MTP -18.50%
MURA -0.30%
MYMD -0.91%
NAMS 3.25%
NAMSW -7.61%
NAUT 1.17%
NBRV 0.71%
NBSE -1.56%
NBTX -6.05%
NCNA -1.64%
NERV 0.00%
NEXI -1.40%
NGM -1.28%
NGNE -3.95%
NKGN 0.78%
NKGNW 39.76%
NKTR -2.14%
NKTX -1.23%
NLSP 144.71%
NLSPW 6.21%
NMRA 0.53%
NMTR -42.97%
NOVN -24.84%
NRBO 0.45%
NRIX 4.43%
NRSN -4.95%
NRSNW 6.50%
NRXP 0.99%
NRXPW -15.65%
NRXS -6.06%
NTBL 2.92%
NTEC -12.45%
NTHI 0%
NTLA 0.00%
NTRBW -6.25%
NUVL -0.03%
NVAX -1.28%
NVCT 1.18%
NVIV -34.28%
NXTC 0.70%
NYMX -0.05%
OABI -0.47%
OABIW 13.46%
OBIO -0.87%
OBSV 0.00%
OCEA -3.21%
OCGN 2.61%
OCS -1.09%
OCUL -1.45%
OCUP 0.00%
ODT -4.27%
OKYO 0.00%
OLMA -0.47%
OMER 0.87%
OMGA 5.65%
ONCO 17.68%
ONCR -3.08%
ONCS 31.87%
ONCT -0.12%
ONCY -0.99%
ONTX -0.47%
ONVO -2.35%
OPNT 0.00%
OPT 0.80%
ORGS -1.72%
ORIC -0.13%
ORMP 0.00%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK 0.26%
OVID -3.76%
OYST 0.00%
PALI 0.86%
PASG -0.99%
PBLA 9.76%
PBM -0.02%
PBYI -0.63%
PCSA 5.71%
PCVX 0.10%
PDSB -0.37%
PEPG 0.70%
PGEN 0.61%
PHAR 2.17%
PHAS 0.00%
PHAT -0.60%
PHIO 6.80%
PHIOW 36.47%
PHVS -0.53%
PHXM -5.20%
PIRS -5.64%
PKBO 0.00%
PKBOW 999 900.00%
PLRX 0.27%
PLUR 0.00%
PMN 0.00%
PMVP 0.00%
PNT 0.16%
PPBT 2.78%
PRAX 5.56%
PRDS 0.93%
PRLD 0.77%
PROG -3.47%
PROK 1.03%
PRQR -2.13%
PRTA 0.34%
PRTC -0.72%
PRTG 6.52%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV 0.00%
PSTX 1.81%
PTCT 0.06%
PTE -0.82%
PTGX 0.03%
PTIXW 2.50%
PULM 3.72%
PXMD -1.92%
PYPD -0.36%
PYXS 0.00%
QLGN 18.52%
QNCX -1.41%
QNRX 3.04%
QSI 0.75%
QSIAW 0.00%
QTTB 0.00%
QURE -0.75%
RAIN -1.63%
RANI 0.00%
RAPT -0.30%
RARE -0.28%
RCKT 0.19%
REGN 0.06%
RENB -1.89%
REPL -0.13%
RETA 0.02%
REUN -0.89%
REVB 5.40%
REVBU 3.46%
REVBW 25.20%
RGLS 0.42%
RGNX 1.12%
RIGL 2.00%
RLAY 1.28%
RLMD 0.00%
RLYB 0.00%
RNA -0.84%
RNAC -1.07%
RNAZ 0.00%
RNXT 0.45%
ROIV 0.37%
ROIVW 4.56%
RPHM -0.60%
RPRX 0.04%
RPTX 1.58%
RUBY 2.70%
RVLP -32.05%
RVMD -0.16%
RVMDW -23.93%
RVNC 0.36%
RVPH 0.00%
RVPHW 11.54%
RXDX 0.09%
RXRX -0.91%
RYTM 0.46%
RYZB 0.02%
RZLT 0.00%
SABS -2.75%
SABSW -32.14%
SAGE 0.71%
SANA -0.17%
SAVA -0.80%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -10.91%
SCPH 0.00%
SCPS 0.00%
SEEL -1.16%
SEER -0.58%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO 1.55%
SGMT -0.47%
SGTX -2.56%
SIOX 22.63%
SLDB -0.40%
SLGL -2.22%
SLN -1.55%
SLNO 0.38%
SLRX 5.16%
SLS -3.04%
SMMT 0.32%
SNDX 0.13%
SNGX 0.79%
SNPX -3.97%
SONN -4.75%
SPPI -0.49%
SPRB 0.49%
SPRC -2.02%
SPRO 3.13%
SRNE 20.00%
SRPT 0.55%
SRRA 0.00%
SRRK -0.34%
SRZN -1.70%
STAB 0.00%
STOK -0.26%
STRO 0.94%
STSA 0.00%
STTK 0.40%
SURF -0.93%
SVRA -0.78%
SWTX -1.42%
SYBX -0.63%
SYRS -2.63%
TALS -0.73%
TARA 0.41%
TARS 1.72%
TBPH -0.12%
TCBP 1.78%
TCDA 0.00%
TCON -1.47%
TCRR 0.00%
TCRT -3.13%
TCRX -1.21%
TECH 0.07%
TENX -3.43%
TERN 0.13%
TFFP -2.05%
TGTX 0.21%
THRX 0.12%
TIL -2.06%
TLC 0.00%
TLSA 0.66%
TNGX 0.59%
TNXP 0.00%
TNYA 0.00%
TPST 0.52%
TRDA -3.61%
TRVI -0.18%
TRVN -1.88%
TSHA -8.93%
TSVT -0.49%
TTNP 1.45%
TVTX -0.27%
TYRA -0.39%
UBX 0.72%
UNCY -0.11%
URGN -7.00%
UTHR 0.08%
VACC 11.36%
VALN -2.51%
VAXX -0.11%
VBIV 1.15%
VBLT -8.77%
VCEL 0.50%
VCNX -1.54%
VCYT -0.09%
VERA -0.08%
VERU 0.50%
VERV -1.33%
VIGL -2.75%
VINC 1.05%
VIR -0.87%
VIRI -5.41%
VIRX -6.84%
VKTX -0.50%
VLON -13.04%
VNDA 0.63%
VOR 0.85%
VRCA 0.00%
VRDN -0.74%
VRNA 1.14%
VRPX -12.13%
VRTX 0.05%
VSTM 0.29%
VTGN 1.46%
VTVT -0.10%
VTYX -0.36%
VXRT 7.83%
VYGR 0.10%
VYNE 2.16%
VYNT 7.78%
WINT 5.59%
WVE -0.67%
XBIO 6.75%
XBIT -0.66%
XCUR -0.65%
XENE 0.30%
XERS 0.53%
XFOR -0.54%
XLO 2.96%
XLRN 0.00%
XNCR -0.41%
XOMA 0.00%
XOMAO -0.56%
XOMAP -0.14%
XRTX 2.88%
YMAB -0.38%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.20%
ZNTL -25.52%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-14 Grossman Adam S Sell 460 000 Common Stock
2024-06-14 Grossman Adam S Sell 10 000 Common Stock
2024-06-14 Grossman Adam S Sell 100 000 Common Stock
2024-04-01 Kestenberg-messina Kaitlin M. Buy 192 320 Common Stock
2024-04-01 Kestenberg-messina Kaitlin M. Buy 300 328 Stock Option (right to buy)
INSIDER POWER
-21.33
Last 100 transactions
Buy: 7 211 788 | Sell: 10 422 560
Koreliacija (AI algo v.1.1b): Undervalued: 0.22% $10.49 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: -0.37 (neutral)
Trumpas: 0.33 (neutral)
Signal:(68.803) Neutral

ADMA Biologics Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
OZEM1
EM0.951
WWD0.945
IESC0.939
APOG0.939
USLM0.937
NATL0.937
JDZG0.934
AEYE0.932
SFM0.928
10 Labiausiai neigiamai susiję koreliacijos
HSDT-0.947
MRAM-0.936
FRSH-0.928
SPT-0.925
CVRX-0.916
NAAS-0.914
OTEX-0.913
FTRE-0.912
BON-0.909
LINK-0.908

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

ADMA Biologics Inc Koreliacija - Valiuta/Žaliavos

The country flag -0.09
( neutral )
The country flag -0.41
( neutral )
The country flag 0.00
( neutral )
The country flag 0.02
( neutral )
The country flag 0.00
( neutral )
The country flag -0.54
( weak negative )

ADMA Biologics Inc Finansinės ataskaitos

Annual 2023
Pajamos: $258.21M
Bruto pelnas: $88.22M (34.16 %)
EPS: $-0.130
FY 2023
Pajamos: $258.21M
Bruto pelnas: $88.22M (34.16 %)
EPS: $-0.130
FY 2022
Pajamos: $154.08M
Bruto pelnas: $35.27M (22.89 %)
EPS: $-0.430
FY 2021
Pajamos: $80.94M
Bruto pelnas: $1.17M (1.45 %)
EPS: $-0.832

Financial Reports:

No articles found.

ADMA Biologics Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

ADMA Biologics Inc

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.

Total Execution Time: 4.3187801837921 seconds
Number of API calls: 3
Number of DB calls: 9